Intestinal Permeability Clinical Trial
Official title:
The Effect of 6 Weeks Supplementation of Probiotic on Exercise-induced Intestinal Permeability in Trained Subjects - a Randomized, Double-blind, Placebo-controlled, Two Armed Parallel Group Trial.
This trial is a single-site, randomised, double blind, placebo-controlled, two-armed parallel-group trial in healthy adult volunteers. The trial will investigate the effect of oral supplementation of a probiotic strain on the ability to attenuate exercise-induced deterioration of intestinal barrier function and gastrointestinal symptoms.
The trial includes a run-in period of two weeks duration followed by a six weeks intervention
period.
After having given their written informed consent, subjects will complete screening
procedures to evaluate their eligibility for the trial and complete a run-in period of
minimum two weeks duration to washout possible pre-trial probiotics. At the screening visit
(visit 1), subjects will also perform a VO2max test on a running treadmill to determine their
individual VO2max.
After baseline assessments at visit 2 and 3, the subjects will be randomly assigned to one of
the two treatment groups (active or placebo product) in a ratio of 1:1. The two arms will be
stratified for gender.
The subjects will consume 1-2 capsules once daily, together with breakfast, for six weeks
starting at Day 1, the day after Visit 3. During the entire run-in and intervention period
the subjects will be asked not to consume any other probiotic products. During the entire
trial subjects should maintain their habitual life style in relation to physical activity
level, diet and sleep habits.
At Visit 2, 3, 4 and 5, the small intestinal permeability will be evaluated by the L:R ratio
measured in urine obtained 5 hours after oral ingestion of a lactulose and rhamnose solution.
The permeability test will be performed in combination with a 1 hour treadmill running
challenge when performed at Visit 3 and Visit 5. The treadmill run will be performed at a
velocity corresponding to 80% of the subjects individually measured VO2max.
Faecal, urine and blood samples will be collected at Visit 2, 3, 4 and 5 for evaluation of
the secondary objectives. The faecal samples collected will be: First bowel movement
post-permeability test at Visit 2, first bowel movement post-exercise test at Visit 3, first
bowel movement post-permeability test at Visit 4 and the first bowel movement post-exercise
at Visit 5.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03957239 -
The Effect of a Cranberry Beverage on Intestinal Permeability and Gastrointestinal Function in Generally Healthy Adults
|
N/A | |
Recruiting |
NCT04543877 -
WHNRC (Western Human Nutrition Research Center) Fiber Intervention Study
|
Early Phase 1 | |
Recruiting |
NCT04109352 -
Labelled Carbon Sucrose Breath Test (13C-SBT) as a Marker of Environmental Enteropathy
|
||
Completed |
NCT01424306 -
Diet and Systemic Inflammation
|
N/A | |
Completed |
NCT01241201 -
Intestinal Barrier Function and Probiotics.
|
N/A | |
Completed |
NCT01477034 -
Vitamin D and Adipose Tissue Inflammation
|
N/A | |
Recruiting |
NCT05257200 -
Gut Permeability and Bariatric-metabolic Surgery
|
||
Completed |
NCT03704727 -
The Effects of Probiotics on Intestinal Permeability in Gastrointestinal Cancer Patients in Chemotherapy
|
N/A | |
Completed |
NCT01049386 -
Intestinal Permeability
|
Phase 2 | |
Recruiting |
NCT04979130 -
Comparing Semaglutide Versus Placebo on Intestinal Barrier Function in Type 2 Diabetes Mellitus (SIB)
|
Phase 4 | |
Recruiting |
NCT06262880 -
Dietary Supplementation on Gastrointestinal Barrier Function
|
N/A | |
Completed |
NCT01756040 -
Intestinal Permeability in Preterm Infants
|
Phase 1 | |
Active, not recruiting |
NCT04083950 -
Induction of Gut Permeability by an Oral Vaccine
|
Early Phase 1 | |
Completed |
NCT03113240 -
Trial of Enteral Glutamine on Intestinal Permeability in Critically Ill Patients
|
Phase 3 |